These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10713126)

  • 1. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.
    Petitclerc E; Boutaud A; Prestayko A; Xu J; Sado Y; Ninomiya Y; Sarras MP; Hudson BG; Brooks PC
    J Biol Chem; 2000 Mar; 275(11):8051-61. PubMed ID: 10713126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. There is temporal and spatial expression of alpha1 (IV), alpha2 (IV), alpha5 (IV), alpha6 (IV) collagen chains and beta1 integrins during the development of the basal lamina in an "in vitro" skin model.
    Fleischmajer R; Kühn K; Sato Y; MacDonald ED; Perlish JS; Pan TC; Chu ML; Kishiro Y; Oohashi T; Bernier SM; Yamada Y; Ninomiya Y
    J Invest Dermatol; 1997 Oct; 109(4):527-33. PubMed ID: 9326385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type IV collagen of the glomerular basement membrane. Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains.
    Boutaud A; Borza DB; Bondar O; Gunwar S; Netzer KO; Singh N; Ninomiya Y; Sado Y; Noelken ME; Hudson BG
    J Biol Chem; 2000 Sep; 275(39):30716-24. PubMed ID: 10896941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
    Maeshima Y; Colorado PC; Kalluri R
    J Biol Chem; 2000 Aug; 275(31):23745-50. PubMed ID: 10837460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis.
    Kalluri R
    Cold Spring Harb Symp Quant Biol; 2002; 67():255-66. PubMed ID: 12858548
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.
    Boosani CS; Mannam AP; Cosgrove D; Silva R; Hodivala-Dilke KM; Keshamouni VG; Sudhakar A
    Blood; 2007 Aug; 110(4):1168-77. PubMed ID: 17426256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes.
    Borza DB; Bondar O; Ninomiya Y; Sado Y; Naito I; Todd P; Hudson BG
    J Biol Chem; 2001 Jul; 276(30):28532-40. PubMed ID: 11375996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha 3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the beta 3 subunit of integrin alpha Vbeta 3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation.
    Pasco S; Monboisse JC; Kieffer N
    J Biol Chem; 2000 Oct; 275(42):32999-3007. PubMed ID: 10934203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
    Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.
    Borza DB; Bondar O; Todd P; Sundaramoorthy M; Sado Y; Ninomiya Y; Hudson BG
    J Biol Chem; 2002 Oct; 277(42):40075-83. PubMed ID: 12193605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.
    Roth JM; Akalu A; Zelmanovich A; Policarpio D; Ng B; MacDonald S; Formenti S; Liebes L; Brooks PC
    Am J Pathol; 2005 Mar; 166(3):901-11. PubMed ID: 15743801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct antitumor properties of a type IV collagen domain derived from basement membrane.
    Maeshima Y; Colorado PC; Torre A; Holthaus KA; Grunkemeyer JA; Ericksen MB; Hopfer H; Xiao Y; Stillman IE; Kalluri R
    J Biol Chem; 2000 Jul; 275(28):21340-8. PubMed ID: 10766752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
    Sudhakar A; Nyberg P; Keshamouni VG; Mannam AP; Li J; Sugimoto H; Cosgrove D; Kalluri R
    J Clin Invest; 2005 Oct; 115(10):2801-10. PubMed ID: 16151532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of type IV collagen and its domains with human mesangial cells.
    Setty S; Kim Y; Fields GB; Clegg DO; Wayner EA; Tsilibary EC
    J Biol Chem; 1998 May; 273(20):12244-9. PubMed ID: 9575174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
    Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis.
    Shahan T; Grant D; Tootell M; Ziaie Z; Ohno N; Mousa S; Mohamad S; Delisser H; Kefalides N
    Connect Tissue Res; 2004; 45(3):151-63. PubMed ID: 15512769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of endostatin with integrins implicated in angiogenesis.
    Rehn M; Veikkola T; Kukk-Valdre E; Nakamura H; Ilmonen M; Lombardo C; Pihlajaniemi T; Alitalo K; Vuori K
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1024-9. PubMed ID: 11158588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion.
    Pedchenko V; Zent R; Hudson BG
    J Biol Chem; 2004 Jan; 279(4):2772-80. PubMed ID: 14610079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells.
    Han J; Ohno N; Pasco S; Monboisse JC; Borel JP; Kefalides NA
    J Biol Chem; 1997 Aug; 272(33):20395-401. PubMed ID: 9252346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An all-D amino acid peptide model of alpha1(IV)531-543 from type IV collagen binds the alpha3beta1 integrin and mediates tumor cell adhesion, spreading, and motility.
    Li C; McCarthy JB; Furcht LT; Fields GB
    Biochemistry; 1997 Dec; 36(49):15404-10. PubMed ID: 9398270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.